Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome

February 4, 2026 updated by: Sergio Mies Padilla

Early Education After a Heart Attack What is the purpose of this study? The main goal is to evaluate if a special nursing education and support program helps patients who have suffered a heart attack feel more confident in managing their own health. Researchers want to see if this extra support improves how patients care for their hearts through diet, physical activity, and quitting smoking. The study compares this new nursing strategy against the standard care patients usually receive.

Who can participate? Participants must be 18 years of age or older. People who have recently had a heart attack requiring an urgent heart catheterization at the Complejo Hospitalario Universitario Insular Materno Infantil.

Exclusions: People with significant language barriers (Spanish), mental incapacity to follow recommendations, or those unable to attend in-person consultations cannot participate.

What will happen during the study? Participants will be divided into two groups: Standard Care Group (Control): These participants will receive the usual medical follow-up and standard cardiac rehabilitation sessions (an average of 17 sessions focused on exercise and group education). Special Support Group (Experimental): In addition to standard care, these participants will have a specific nursing consultation consisting of 4 scheduled visits.

These visits are a mix of in-person and telephone appointments.Nurses will provide personalized educational materials, such as infographics, and teach techniques to control blood pressure, improve diet, exercise safely, and manage emotions after a heart attack.

Duration and Follow-up Each participant will be followed for approximately 8 months. During this time, they will be asked to complete several surveys about their lifestyle.

Researchers will also review blood test results (cholesterol levels) from their medical records to track progress.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

256

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Cristina María Torres Moreno
  • Phone Number: +34928444000 (ext:71363)
  • Email: isocrimi@gmail.com

Study Locations

    • Las Palmas
      • Las Palmas de Gran Canaria, Las Palmas, Spain, 35001
        • Recruiting
        • Complejo Hospitalario Universitario Insular Materno Infantil De Gran Canaria
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients must have suffered an Acute Myocardial Infarction.
  • Participants must have undergone an urgent cardiac catheterization.
  • Specifically, this includes patients who received coronary reperfusion strategies following the activation of the CODICAN protocol (assistance for ST-segment elevation myocardial infarction) within the study environment.

Exclusion Criteria:

  • Patients with little or no knowledge of the Spanish language that prevents effective communication or reading of educational resources.
  • Patients unable to understand their participation or follow health recommendations independently.
  • Patients with an unfavorable clinical prognosis or those requiring hospitalization for a period exceeding established limits.
  • Patients unable to attend in-person nursing consultations due to personal reasons or place of residence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
The intervention for the experimental group consists of specialized and structured nursing care provided in addition to standard medical treatment. This program is organized into four key stages: it begins with an initial contact during hospital admission to explain the objectives and assess baseline risks. Subsequently, between 7 and 10 days after discharge, a 60-minute in-person visit is conducted to perform a complete medical history and deliver adapted educational materials on heart-healthy habits. Four months after the event, a telephone reinforcement session is held to monitor treatment adherence and lifestyle changes. Finally, eight months after discharge, an in-person evaluation is carried out to measure the achievement of goals and, if necessary, refer the patient to other specialists. The entire process is supported by the use of infographics and evidence-based educational materials focused on blood pressure control, diet, exercise, and emotional health.
Used to verify the patient's understanding of their condition and to motivate behavioral changes.
Specific counseling to improve adherence to the Mediterranean diet and address overweight or obesity
Interventions aimed at increasing motivation to quit smoking and reducing nicotine dependence
Personalized exercise recommendations tailored to the patient's clinical status
Professional support to address emotional well-being, detecting potential states of anxiety or depression following the acute event.
Continuous education and monitoring to ensure compliance with the prescribed pharmacological plan
Training the patient for autonomous monitoring of risk factors, such as blood pressure
Provision of adapted materials (infographics and written documents) to permanently reinforce healthy knowledge and behaviors
Upon hospital discharge, all patients are referred to a cardiac rehabilitation unit. The program consists of an average of 17 sessions focused primarily on the physical rehabilitation of the patient. Patients receive group-based health education provided by nursing professionals during these sessions.These rehabilitation sessions are typically completed within three months following the coronary event. Patients continue to receive medical and nursing attention through specialized care centers or primary care. Both groups receive optimal pharmacological treatment and general advice on cardiovascular health, including physical activity and diet.
Active Comparator: Control Group
The Control Group consists of patients who receive the standard healthcare provided by the hospital after a heart attack. These participants are recruited retrospectively using the hospital's hemodynamic service records. After discharge, they participate in the standard cardiac rehabilitation program, which typically includes 17 sessions of physical exercise and group health education. Their data is collected through a single telephone interview approximately 8 months after their heart attack to evaluate their lifestyle habits, emotional state, and clinical progress.
Upon hospital discharge, all patients are referred to a cardiac rehabilitation unit. The program consists of an average of 17 sessions focused primarily on the physical rehabilitation of the patient. Patients receive group-based health education provided by nursing professionals during these sessions.These rehabilitation sessions are typically completed within three months following the coronary event. Patients continue to receive medical and nursing attention through specialized care centers or primary care. Both groups receive optimal pharmacological treatment and general advice on cardiovascular health, including physical activity and diet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiac Self-Efficacy
Time Frame: Experimental Group: measured at two time points: baseline (during hospitalization) and 8 months (post-coronary event). Control Group: measured only at the 8-month mark post-coronary event to evaluate the level of self-efficacy after receiving standard
His measure evaluates specific behaviors related to cardiovascular health using the Spanish-validated version of the Cardiac Self-Efficacy Scale (S-CSE). This tool consists of 12 items across three dimensions: symptom control, disease control, and activity maintenance. Each item is rated on a 7-point Likert scale (1 = not at all confident, 7 = completely confident). Total scores range from 12 to 84, where higher scores indicate better self-efficacy
Experimental Group: measured at two time points: baseline (during hospitalization) and 8 months (post-coronary event). Control Group: measured only at the 8-month mark post-coronary event to evaluate the level of self-efficacy after receiving standard

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to the Mediterranean Diet
Time Frame: Experimental Group: baseline and 8 months Control Group: 8 months only
Measured using the MEDAS questionnaire (14 items). Higher scores indicate greater adherence to a heart-healthy diet
Experimental Group: baseline and 8 months Control Group: 8 months only
Nicotine Dependence
Time Frame: Experimental Group: baseline and 8 months Control Group: 8 months only
Assessed using the Fagerström Test (6 items). Scores range from 0 to 10, where greater than or equal to 7 indicates high dependence
Experimental Group: baseline and 8 months Control Group: 8 months only
Motivation to Quit Smoking
Time Frame: Experimental Group: Baseline and 8 months . Control Group: 8 months only.
Evaluated through the Richmond Test (4 items). Scores range from 0 to 10; scores between 8-10 indicate high motivation.
Experimental Group: Baseline and 8 months . Control Group: 8 months only.
Physical Activity Level
Time Frame: Experimental Group: Baseline and 8 months Control Group: 8 months only.
Measured using the International Physical Activity Questionnaire (IPAQ). It categorizes patients into high, moderate, or low activity levels based on METs.
Experimental Group: Baseline and 8 months Control Group: 8 months only.
Affective State (Anxiety and Depression)
Time Frame: Experimental Group: Baseline and 8 months Control Group: 8 months only
Determined using the Goldberg Scale. It consists of two subscales (anxiety mayor o igual a 4 and depression greater than or equal to 2) to detect psychological distress
Experimental Group: Baseline and 8 months Control Group: 8 months only
Lipid Profile
Time Frame: Experimental Group: Baseline and 8 months Control Group: 8 months only
Clinical data collection of total cholesterol, LDL, HDL, and triglycerides from medical records
Experimental Group: Baseline and 8 months Control Group: 8 months only
Cardiac Rehabilitation Adherence
Time Frame: 8 months (for both groups)
Exploration of patient inclusion, adherence (number of sessions attended), and group education received
8 months (for both groups)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

January 28, 2026

First Submitted That Met QC Criteria

February 4, 2026

First Posted (Actual)

February 11, 2026

Study Record Updates

Last Update Posted (Actual)

February 11, 2026

Last Update Submitted That Met QC Criteria

February 4, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Currently, there is no plan to share individual participant data (IPD) with external researchers or public platforms. According to the protocol, the collected data will be used exclusively for the research purposes of this specific study, and only the research team will have access to the anonymized database. Patient privacy is protected by current regulations (Spanish Organic Law 3/2018), ensuring that information is treated confidentially and securely within the hospital environment.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Clinical Trials on Motivational and Individualized Interviewing

Subscribe